GE HealthCare Technologies Inc (NASDAQ: GEHC) has a price-to-earnings ratio that is above its average at 15.97x. The stock has a 36-month beta value of 1.29. Opinions on the stock are mixed, with 12 analysts rating it as a “buy,” 4 as “overweight,” 5 as “hold,” and 0 as “sell.”
The public float for GEHC is 456.44M, and at present, short sellers hold a 1.40% of that float. On July 02, 2025, the average trading volume of GEHC was 5.08M shares.
GEHC) stock’s latest price update
GE HealthCare Technologies Inc (NASDAQ: GEHC)’s stock price has plunge by 2.54relation to previous closing price of 74.07. Nevertheless, the company has seen a 5.52% surge in its stock price over the last five trading sessions. businesswire.com reported 2025-07-01 that CHICAGO–(BUSINESS WIRE)–The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the second quarter of 2025 payable on August 15, 2025 to all shareholders of record as of July 25, 2025. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled sol.
GEHC’s Market Performance
GE HealthCare Technologies Inc (GEHC) has seen a 5.52% rise in stock performance for the week, with a 7.67% gain in the past month and a -5.90% plunge in the past quarter. The volatility ratio for the week is 2.69%, and the volatility levels for the past 30 days are at 2.12% for GEHC. The simple moving average for the past 20 days is 4.60% for GEHC’s stock, with a -6.00% simple moving average for the past 200 days.
Analysts’ Opinion of GEHC
Many brokerage firms have already submitted their reports for GEHC stocks, with UBS repeating the rating for GEHC by listing it as a “Neutral.” The predicted price for GEHC in the upcoming period, according to UBS is $73 based on the research report published on May 05, 2025 of the current year 2025.
Goldman, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $100, previously predicting the price at $85. The rating they have provided for GEHC stocks is “Buy” according to the report published on March 11th, 2025.
Jefferies gave a rating of “Buy” to GEHC, setting the target price at $103 in the report published on January 08th of the current year.
GEHC Trading at 7.29% from the 50-Day Moving Average
After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.88% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GEHC starting from Newcomb George A., who sale 2,000 shares at the price of $92.54 back on Feb 18 ’25. After this action, Newcomb George A. now owns 7,462 shares of GE HealthCare Technologies Inc, valued at $185,080 using the latest closing price.
Rott Roland, the CEO, Imaging of GE HealthCare Technologies Inc, sale 3,577 shares at $86.48 during a trade that took place back on Nov 06 ’24, which means that Rott Roland is holding 24,298 shares at $309,339 based on the most recent closing price.
Stock Fundamentals for GEHC
Current profitability levels for the company are sitting at:
- 0.14 for the present operating margin
- 0.42 for the gross margin
The net margin for GE HealthCare Technologies Inc stands at 0.11. The total capital return value is set at 0.12. Equity return is now at value 26.32, with 6.64 for asset returns.
Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.5 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 1.0. The interest coverage ratio of the stock is 5.73.
Currently, EBITDA for the company is 3.68 billion with net debt to EBITDA at 1.92. When we switch over and look at the enterprise to sales, we see a ratio of 2.1. The receivables turnover for the company is 4.55for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.94.
Conclusion
To sum up, GE HealthCare Technologies Inc (GEHC) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
